LPL Financial’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-10,240
Closed -$133K – 5807
2025
Q2
$133K Sell
10,240
-72
-0.7% -$851 ﹤0.01% 5206
2025
Q1
$109K Sell
10,312
-1,184
-10% -$18.8K ﹤0.01% 5021
2024
Q4
$195K Sell
11,496
-806
-7% -$15.2K ﹤0.01% 4823
2024
Q3
$286K Sell
12,302
-570
-4% -$12.2K ﹤0.01% 4477
2024
Q2
$313K Sell
12,872
-469
-4% -$14.2K ﹤0.01% 4232
2024
Q1
$451K Sell
13,341
-100
-0.7% -$3.54K ﹤0.01% 3877
2023
Q4
$424K Sell
13,441
-570
-4% -$13.5K ﹤0.01% 3793
2023
Q3
$358K Buy
+14,011
New +$432K ﹤0.01% 3763
2022
Q2
– Sell
-13,041
Closed -$352K – 4423
2022
Q1
$352K Buy
13,041
+3,995
+44% +$102K ﹤0.01% 3457
2021
Q4
$335K Buy
9,046
+357
+4% +$14.5K ﹤0.01% 3607
2021
Q3
$415K Sell
8,689
-410
-5% -$18.4K ﹤0.01% 3386
2021
Q2
$308K Buy
9,099
+3,080
+51% +$104K ﹤0.01% 3573
2021
Q1
$249K Buy
6,019
+636
+12% +$37.9K ﹤0.01% 3604
2020
Q4
$234K Buy
+5,383
New +$365K ﹤0.01% 3402

Other funds holding ARCT

LPL Financial's ARCT Position: Q3 2025 in Review

LPL Financial sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 10,240 shares — an estimated $133K sold.

LPL Financial first reported a position in ARCT in Q4 2020 and held it in 14 quarters. The position peaked at $451K in Q1 2024. 137 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • LPL Financial reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 10,240 Arcturus Therapeutics shares in Q3 2025, an estimated $133K.
  • LPL Financial first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 14 quarters.
  • LPL Financial's Arcturus Therapeutics position peaked at $451K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.